Retracted: Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia
- PMID: 37565218
- PMCID: PMC10412145
- DOI: 10.1155/2023/9764181
Retracted: Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia
Abstract
[This retracts the article DOI: 10.1155/2022/7366432.].
Copyright © 2023 Evidence-Based Complementary and Alternative Medicine.
Retraction of
-
Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia.Evid Based Complement Alternat Med. 2022 Aug 19;2022:7366432. doi: 10.1155/2022/7366432. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Aug 2;2023:9764181. doi: 10.1155/2023/9764181. PMID: 36034963 Free PMC article. Retracted.
References
-
- Li W., Zhu H., Wen L., Quan M., Wang L. Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia. Evidence-Based Complementary and Alternative Medicine . 2022;2022:5. doi: 10.1155/2022/7366432.7366432 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
